Metal framework compound nanocarrier delivery system for targeted activation of cd44 molecule, preparation method and use thereof
A technology of nano-carrier and delivery system, which can be applied to inactive components of polymer compounds, preparations for in vivo tests, nano-drugs, etc., and can solve problems such as non-existence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach
[0120] The present invention will be further illustrated by specific examples below, however, it should be understood that these examples are only used for more detailed description, and should not be construed as limiting the present invention in any form.
[0121] This section provides a general description of the materials and test methods used in the tests of the present invention. While many of the materials and methods of manipulation which are employed for the purposes of the invention are well known in the art, the invention has been described here in as much detail as possible. It will be apparent to those skilled in the art that, in the context and context, the materials used and methods of operation used in the present invention are known in the art unless otherwise specified.
Embodiment 1
[0122] Example 1 Preparation of loaded rosuvastatin (R) metal framework compound (MOF-(R)-HA) nano-delivery system coupled with hyaluronic acid (HA)
[0123] This patent uses terephthalic acid (H 2 BDC) and magnesium ions (Mg 2+ ) Prepare MOF-7 drug carrier, load therapeutic drugs and contrast agents, and connect hyaluronic acid targeting molecules on its surface to realize target recognition and drug delivery.
[0124] 1.1 Preparation of blank MOF-7 carrier: H 2 BDC (5g) was dissolved in 10mL DMF, and 10mg mL was added dropwise under stirring at 50°C -1 Mg(NO 3 ) 2Aqueous solution, a white emulsion can be seen, continue to react under these conditions for 24 hours, and centrifuge at high speed to obtain a white product of MOF-7. figure 1 It is the X-ray diffraction peak (XRD) of blank carrier MOF-7.
[0125] 1.2 Preparation of rosuvastatin (R) metal framework compound (MOF-(R)) nano-delivery system: 10mgmL -1 Mg(NO 3 ) 2 Aqueous solution and 10mg mL -1 Rosuvastatin...
Embodiment 2
[0127] Example 2 Preparation of rosuvastatin (R) MOF-7 nanocarrier (MOF-(R)-SP) delivery system coupled with selectin (SP)
[0128] MOF-(R) loaded with rosuvastatin was prepared according to the method in Example 1.
[0129] Dissolve 1 mg of selectin SP in PBS buffer solution, add 0.5 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC.HCl) and 0.5 mg of N-hydroxy The sulfosuccinimide (sulfo-NHS) coupling reagent activates the carboxyl group. After stirring the reaction at room temperature for 1 hour. Configure it to 1mg mL -1 1mL solution was taken and dissolved in the purified MOF-(R) solution to realize the coupling of SP on MOF-(R) to obtain the targeted recognition nanocarrier MOF-(R)-SP. image 3 Infrared spectra of blank MOF-7 and MOF-(R)-SP metal framework nanocarriers.
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
length | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com